DEEP MEDICINE ACQUISITI-CL A (DMAQ) Stock Price, Quote, News and Overview
NASDAQ:DMAQ - Nasdaq - US2437331026 - Common Stock - Currency: USD
DMAQ Quote, Performance and Key Statistics
2.96
-5.43 (-64.72%)
The current stock price of DMAQ is 2.96 USD. In the past month the price decreased by -74.37%. In the past year, price decreased by -70.61%.
About DMAQ
Company Profile
Deep Medicine Acquisition Corp. is a blank check company, which aims on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in Plantation, Florida. The company went IPO on 2021-10-27. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The firm intends to focus its search on the healthcare and education service industries. The firm is not engaged in any business operations and has not generated any revenue.
Company Info
DEEP MEDICINE ACQUISITI-CL A
7951 S.W. 6Th Street, Suite 216
Plantation FLORIDA US
Employees: 0
Phone: 19544242345
DEEP MEDICINE ACQUISITI-CL A / DMAQ FAQ
What is the stock price of DEEP MEDICINE ACQUISITI-CL A today?
The current stock price of DMAQ is 2.96 USD. The price decreased by -64.72% in the last trading session.
What is the ticker symbol for DEEP MEDICINE ACQUISITI-CL A stock?
The exchange symbol of DEEP MEDICINE ACQUISITI-CL A is DMAQ and it is listed on the Nasdaq exchange.
On which exchange is DMAQ stock listed?
DMAQ stock is listed on the Nasdaq exchange.
What is DEEP MEDICINE ACQUISITI-CL A worth?
DEEP MEDICINE ACQUISITI-CL A (DMAQ) has a market capitalization of 12.91M USD. This makes DMAQ a Nano Cap stock.
How many employees does DEEP MEDICINE ACQUISITI-CL A have?
DEEP MEDICINE ACQUISITI-CL A (DMAQ) currently has 0 employees.
Should I buy DEEP MEDICINE ACQUISITI-CL A (DMAQ) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of DMAQ, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of DMAQ, evaluating the profitability, health, valuation and growth aspects
- DEEP MEDICINE ACQUISITI-CL A (DMAQ) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DEEP MEDICINE ACQUISITI-CL A (DMAQ) Sales and EPS estimates to see what analysts future expectations are.
- DEEP MEDICINE ACQUISITI-CL A (DMAQ) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DEEP MEDICINE ACQUISITI-CL A (DMAQ) Insider and Institutional Ownership to learn about the owners and their transactions.
- DEEP MEDICINE ACQUISITI-CL A (DMAQ) Stock Chart to make your own analysis
- DEEP MEDICINE ACQUISITI-CL A (DMAQ) Latest news and press-releases to stay up to date.
Does DEEP MEDICINE ACQUISITI-CL A (DMAQ) stock pay dividends?
DMAQ does not pay a dividend.
What is the Price/Earnings (PE) ratio of DEEP MEDICINE ACQUISITI-CL A (DMAQ)?
DEEP MEDICINE ACQUISITI-CL A (DMAQ) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.17).
DMAQ Technical Analysis
DMAQ Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to DMAQ. The financial health of DMAQ is average, but there are quite some concerns on its profitability.
DMAQ Financial Highlights
Over the last trailing twelve months DMAQ reported a non-GAAP Earnings per Share(EPS) of -0.17. The EPS decreased by -466.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -5.1% | ||
| ROE | -22.17% | ||
| Debt/Equity | 0 |